Zdrowie i gospodarka · 03/08/2005

FDA to Host 2-Day Workshop on Developing Prevention Therapies as Part of Critical Path Initiative

The FDA is planning a 2-day workshop to discuss approaches and challenges in developing prevention therapies for diseases such as cancer, diabetes, and obesity, as part of its Critical Path Initiative